Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Dexcom Inc (NQ: DXCM )

129.01 -9.00 (-6.52%)
Streaming Delayed Price Updated: 11:10 AM EDT, Apr 26, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Dexcom Inc

< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
19 20 Next >
Elliott Wave Technical Analysis: DexCom Inc. - Tuesday, April 11
We are looking for further upside in wave (C) as we are seeing what appears to be a triangle in wave (B). 
Via Talk Markets
1 Stock-Split Stock That's a Surefire April Buy and 1 to Avoid
One stock-split stock is executing flawlessly and seeing its operating margin climb, while another widely held company is flashing warning signs. 
Via The Motley Fool
A Nasdaq Bull Market Is Coming: 2 Fantastic Stocks to Buy and Hold
Investing is a long-term game, and both of these companies are thinking that way. 
Via The Motley Fool
P/E Ratio Insights for DexCom
Via Benzinga
3 No-Brainer Medical Device Stocks to Buy Right Now
These companies have consistently delivered revenue and EPS gains. 
Via The Motley Fool
2 Explosive Growth Stocks to Buy in April
These businesses look to be on solid footing even in a difficult operating environment. 
Via The Motley Fool
Here's How Much You Would Have Made Owning DexCom Stock In The Last 5 Years
Via Benzinga
Analyst Ratings for DexCom
Via Benzinga
Where Will DexCom Be in 1 Year?
The company may only be scratching the surface of its target market. 
Via The Motley Fool
Price Over Earnings Overview: DexCom
Via Benzinga
2 All-Weather Stocks to Buy Without Hesitation Right Now
Despite near-term economic clouds, long-term investors can still find compelling buying opportunities. 
Via The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023
Via Benzinga
Nasdaq Bear Market: 2 Growth Stocks to Buy That Keep Bucking the Trend
These red-hot stocks keep climbing despite the bear market. 
Via The Motley Fool
Elliott Wave Technical Analysis: DexCom Inc.
Looking for another leg higher before potential downside resumption. 
Via Talk Markets
$1000 Invested In This Stock 5 Years Ago Would Be Worth $6,900 Today
Via Benzinga
(DXCM) - Analyzing DexCom's Short Interest
Via Benzinga
Have $1,000? 2 Stock-Split Companies to Add to Your Buy Basket Right Now.
Don't overlook these names in the current market. 
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Stock Market Tumbles Amid SVB Financial Collapse, 'Faster' Powell: Weekly Review
The major indexes suffered serious losses this past week. 
Via Investor's Business Daily
2 Top Stocks to Buy in March and Hold Forever
Don't let a turbulent market keep you on the sidelines this month. 
Via The Motley Fool
Want to Get Richer? 2 Top Stocks to Buy Now and Hold Forever
A bull market could supercharge these two top stocks. 
Via The Motley Fool
Here's How Much You Would Have Made Owning DexCom Stock In The Last 5 Years
Via Benzinga
5 Stocks That Powered Nasdaq ETF Last Week
Here are the five best-performing stocks of QQQ from last week that led the way higher in the portfolio. 
Via Talk Markets
Dexcom Pummeled On A New FDA Clearance For Key Rival Abbott Laboratories
The FDA will allow two of Abbott's CGMs to be paired with automated insulin pumps. 
Via Investor's Business Daily
Stock Market Rally Rebounds Despite Rising Yields; Salesforce, Tesla In Focus: Weekly Review
Many leaders flashed buy signals as the indexes rebounded from support. 
Via Investor's Business Daily
1 High-Flying Growth Stock With 19% Upside, According to Wall Street
This company could keep going up, but beware of the risks. 
Via The Motley Fool
Dexcom Nears Breakout On A Surprise Medicare Decision For Its Devices
The decision came months ahead of Dexcom's and Abbott's expectations. 
Via Investor's Business Daily
Where to Invest $1,000 in a 2023 Nasdaq Bear Market
Even a modest investment in great companies can pay off over the long run. 
Via The Motley Fool
Should Abbott and DexCom Investors Be Worried About Apple's Latest News?
The continuous glucose monitoring market could heat up. 
Via The Motley Fool
What Do Sanofi And Dexcom See In DarioHealth That The Market Is Missing?
DarioHealth (NASDAQ: DRIO) Partners With Dexcom (NASDAQ: DXCM) The Global Leader in Continuous Glucose Monitoring (CGM) To Integrate Dario's Multi-Chronic Condition Platform. 
Via News Direct
< Previous 1 2
...
7 8 9 10 11 12 13 14 15
...
19 20 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.